AGP Pharma
Zerifax 550mg 10 Tablets
Zerifax 550mg 10 Tablets
Product Overview
Product Form: Tablet
Pack Size: 10 Tablets
Manufactured By: AGP Pharma
Prescription Required: Yes
Product Details
Zerifax 550mg Tablets are a potent antibacterial medication containing Rifaximin. They are primarily used to treat bacterial infections, especially those caused by non-invasive strains of Escherichia coli. The active ingredient, Rifaximin, binds to bacterial RNA polymerase, inhibiting RNA synthesis and reducing the production of neurotoxins that contribute to conditions such as hepatic encephalopathy.
Purposes
The primary purpose of Zerifax 550mg Tablets is to manage bacterial infections, particularly in the gut, and to reduce the recurrence of hepatic encephalopathy. By targeting specific bacteria, these tablets help control and prevent infections, ensuring better health outcomes.
Warnings
-
Clostridium difficile-associated diarrhea (CDAD) has been reported with the use of antibacterial agents like Zerifax 550mg Tablets. This condition can range from mild diarrhea to fatal colitis. If CDAD is suspected or confirmed, discontinuation of non-essential antibiotics may be required.
-
Rifaximin should be used cautiously in patients with diarrhea caused by pathogens other than Escherichia coli, and alternative antibiotic therapies should be considered if symptoms worsen or persist for more than 24-48 hours.
-
The use of Zerifax 550mg Tablets in pregnancy should be avoided unless clearly necessary, as it may harm the unborn baby. Consult with a healthcare provider to assess the risks and benefits.
Adverse Effects
Common side effects of Zerifax 550mg Tablets include headaches, abdominal pain, and nausea. In patients with hepatic encephalopathy, side effects may also include peripheral edema, dizziness, and fatigue. Less common but possible adverse reactions include dehydration, hypoglycemia, and muscle spasms. Severe reactions like Clostridium difficile-associated diarrhea, although rare, require immediate medical attention.
Cautions
Patients using Zerifax 550mg Tablets should be aware of the risk of worsening symptoms if the infection is caused by pathogens other than Escherichia coli. It is important to monitor symptoms and consult a healthcare provider if conditions do not improve. Long-term use should be under medical supervision, especially in those with pre-existing liver conditions.